AUG 06, 2018 5:00 AM PDT

Cannabidivarin...The Next Medicinal Phytocannabinoid?

WRITTEN BY: Mauri Brueggeman

There are over 100 phytocannabinoids in the Cannabis sativa plant; while 9-tetrahydrocannabinol (THC) and cannabidiol (CBD) have gained the most attention in the past few decades for multiple reasons, there are others being found to contribute medicinally as well.  Cannabidivarin (CBDV) is one of those currently being looked at clinically for its anticonvulsant properties as well as its potential ability to help in mouse models of conditions with brain atrophy. 

CBDV was first found and isolated as a phytocannabinoid in 1969 and is believed to work via cannabinoid receptor 2 (CB2) dependent mechanisms and other means as part of our human endocannabinoid system.  CBD and CBDV are structurally similar; they differ by a single shortened carbon side chain on CBDV (2 less carbons).

In a study published back in 2012, CBDV administered p.o. (per os) was examined and found to be effective as an effective anticonvulsant with little motor side effect.  Many anti-seizure drugs have considerable side effects at a clinically effective dose; additionally, epilepsy treatments must be successfully administered as an oral therapy.  The researchers used a CBDV solution of varying concentrations (50, 100, or 200 mgkg-1 in ethanol) from GW Pharmaceuticals.  Notably, GW Pharmaceuticals is the company that produces Epidiolex, the first FDA approved epilepsy drug, approved in late June 2018, based on phytocannabinoids and not synthetic cannabinoids.

A more recent study, published July 26, 2018, continues the work with CBDV as a clinically relevant alternative for treatments involving neurological change.  The study, published in Neuropharmacology, investigated the use of CBDV for Rett Syndrome symptoms including behavioral alterations and brain atrophy as a result of the condition.  Rett syndrome is a neurodevelopment disorder caused by mutations in the MECP2 gene in almost all cases (reportedly 95%).  It is a rare condition and no cure has been found to date.  Rett syndrome is usually recognized in infancy in girls but is noticed later in boys and has similar characteristics to autism including cerebral palsy or non-specific developmental delay.  As mentioned, the syndrome is caused my mutations of the MECP2 gene found on the X chromosome and affects brain function, notably in cognition as well as affecting sensory, autonomic, motor, and emotional abilities.  Many of the processes that result in impaired brain function in Rett syndrome are connected to the physiologically regulated processes of the endocannabinoid system. Researchers used animal models of Rett syndrome to evaluate the efficacy of CBDV administered for 14 days.  The group reported that the treatment rescued behavioral and brain alterations, reestablished a healthy baseline status including brain weight.  They also observed notably improved motor coordination.  They evaluated the mechanism for these changes and found increased levels of a G protein-coupled receptor 55 (GPR55) in the mouse hippocampus.  It has been established that GPR55 is an antagonist of GPR55 so the authors suggest these findings indicate this G protein receptor may be a potential target for treatment of this particular condition.  In any case, the potential for further study with CBDV as a valuable therapeutic option will continue. 

Sources: NCI Open Chemistry Database, Neuropharmacology, British Journal of Pharmacology, Rettsyndrome.org,

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
JUN 07, 2020
Cannabis Sciences
Should You Smoke Cannabis Seeds and Stems?
JUN 07, 2020
Should You Smoke Cannabis Seeds and Stems?
When smoking cannabis, people typically use either the flower, buds, or leaves. But what about the seeds and stems? Can ...
JUN 15, 2020
Cannabis Sciences
Prenatal Cannabis Exposure Does Not Cause Brain Damage in Children
JUN 15, 2020
Prenatal Cannabis Exposure Does Not Cause Brain Damage in Children
Parents and their children often face separation and other punishments due to the idea that prenatal cannabis exposure c ...
AUG 10, 2020
Cannabis Sciences
Cannabis Use During Pregnancy Linked to Autism
AUG 10, 2020
Cannabis Use During Pregnancy Linked to Autism
Researchers from The Ottawa Hospital in Ontario, Canada, have found that children born to mothers who used cannabis whil ...
AUG 14, 2020
Health & Medicine
Does Legalization of Cannabis Mean Users Actually Use Legal Sources?
AUG 14, 2020
Does Legalization of Cannabis Mean Users Actually Use Legal Sources?
Recent research from states that have legalized recreational cannabis, looked at whether users find the drug  is mo ...
AUG 25, 2020
Cannabis Sciences
Synthetic Cannabinoid Drug to Enter Human Trials
AUG 25, 2020
Synthetic Cannabinoid Drug to Enter Human Trials
In recent months, interest has been growing in the potential for cannabinoids- the compounds found in cannabis- to treat ...
SEP 01, 2020
Plants & Animals
Warsaw Zoo Testing CBD to Manage Elephants' Stress
SEP 01, 2020
Warsaw Zoo Testing CBD to Manage Elephants' Stress
Humans use cannabidiol (CBD) for its array of health benefits, and household pets even benefit from CBD treatments in sp ...
Loading Comments...